Clinical Trial Update: Comparing Intravitreal Aflibercept Monotherapy vs Aflibercept Combined With Reduced Fluence PDT in PCV Treatment [NA]

View source ↗

Summary

Clinical trial update comparing intravitreal aflibercept monotherapy to aflibercept with reduced fluence PDT for Polypoidal Choroidal Vasculopathy. The study st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Polypoidal Choroidal Vasculopathy

Drugs mentioned

• Eylea (aflibercept) (aflibercept)

Snippet

Sponsor: Singapore National Eye Centre | Conditions: Polypoidal Choroidal Vasculopathy | NA | Status: COMPLETED